Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja UBC Medical Indonesia Tbk. (LABS) vs Multi Indocitra Tbk. (MICE)

UBC Medical Indonesia Tbk.Trading
Multi Indocitra Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan UBC Medical Indonesia Tbk. dan Multi Indocitra Tbk.: UBC Medical Indonesia Tbk. diperdagangkan di Rp148 (kapitalisasi pasar 576,7 M, volume 24 jam 3,48 jt), sedangkan Multi Indocitra Tbk. diperdagangkan di Rp530 (kapitalisasi pasar 303 M, volume 24 jam 154,1 rb). Perbedaan utamanya: UBC Medical Indonesia Tbk. lebih besar dari sisi kapitalisasi pasar, dan UBC Medical Indonesia Tbk. lebih aktif diperdagangkan (3,48 jt vs 154,1 rb). Mana yang lebih baik tergantung tujuan investasimu.

LABSMICE
Kapitalisasi Pasar
576,7 M303 M
Volume
3,48 jt154,1 rb
Lot
34,82 rb1,54 rb
Perputaran
522,79 jt81,24 jt
Harga Rata-rata
150,13527,17
Nilai Transaksi
522,79 jt81,24 jt
Harga Ekuilibrium Indikatif
148
Volume Ekuilibrium Indikatif
350

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

LABS
Lihat detail
MICE
Lihat detail

Tentang UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Selengkapnya di halaman LABS

Tentang Multi Indocitra Tbk.

PT Multi Indocitra Tbk (the Company) was established under its original name of Modern Indocitra based on notarial deed No. 52 of Esther Daniar Iskandar, S.H dated January 11, 1990. The Company's articles of association has been amended several times, the latest amendment dated Aug 16, 2005, regarding the change in the Company's status from private company to public company.

Selengkapnya di halaman MICE